Article Details

On Path to First-in-Human Study, NurExone Engages Prominent - GlobeNewswire

Retrieved on: 2024-06-21 20:06:38

Tags for this article:

Click the tags to see associated articles and topics

On Path to First-in-Human Study, NurExone Engages Prominent - GlobeNewswire. View article details on hiswai:

Summary

The article discusses the engagement of Dr. Yona Geffen by NurExone Biologic Inc. to advance their regenerative medicine efforts, focusing on exosome-based drug development and clinical trials, aligning well with the tags on drug discovery and development.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up